183 related articles for article (PubMed ID: 18533993)
1. Optimization of the doxycycline-dependent simian immunodeficiency virus through in vitro evolution.
Das AT; Klaver B; Centlivre M; Harwig A; Ooms M; Page M; Almond N; Yuan F; Piatak M; Lifson JD; Berkhout B
Retrovirology; 2008 Jun; 5():44. PubMed ID: 18533993
[TBL] [Abstract][Full Text] [Related]
2. Construction of a doxycycline-dependent simian immunodeficiency virus reveals a nontranscriptional function of tat in viral replication.
Das AT; Klaver B; Harwig A; Vink M; Ooms M; Centlivre M; Berkhout B
J Virol; 2007 Oct; 81(20):11159-69. PubMed ID: 17670816
[TBL] [Abstract][Full Text] [Related]
3. Conditionally replicating HIV and SIV variants.
Das AT; Berkhout B
Virus Res; 2016 May; 216():66-75. PubMed ID: 25982510
[TBL] [Abstract][Full Text] [Related]
4. Tat has a dual role in simian immunodeficiency virus transcription.
van der Velden GJ; Vink MA; Berkhout B; Das AT
J Gen Virol; 2012 Oct; 93(Pt 10):2279-2289. PubMed ID: 22815271
[TBL] [Abstract][Full Text] [Related]
5. Modification of the Tet-On regulatory system prevents the conditional-live HIV-1 variant from losing doxycycline-control.
Zhou X; Vink M; Berkhout B; Das AT
Retrovirology; 2006 Nov; 3():82. PubMed ID: 17094796
[TBL] [Abstract][Full Text] [Related]
6. The genetic stability of a conditional live HIV-1 variant can be improved by mutations in the Tet-On regulatory system that restrain evolution.
Zhou X; Vink M; Klaver B; Verhoef K; Marzio G; Das AT; Berkhout B
J Biol Chem; 2006 Jun; 281(25):17084-17091. PubMed ID: 16627480
[TBL] [Abstract][Full Text] [Related]
7. Conditional virus replication as an approach to a safe live attenuated human immunodeficiency virus vaccine.
Berkhout B; Verhoef K; Marzio G; Klaver B; Vink M; Zhou X; Das AT
J Neurovirol; 2002 Dec; 8 Suppl 2():134-7. PubMed ID: 12491165
[TBL] [Abstract][Full Text] [Related]
8. Dox-dependent SIVmac with tetracycline-inducible promoter in the U3 promoter region.
Xiao Y; Kuwata T; Miura T; Hayami M; Shida H
Virology; 2000 Apr; 269(2):268-75. PubMed ID: 10753705
[TBL] [Abstract][Full Text] [Related]
9. Functional analysis of the complex trans-activating response element RNA structure in simian immunodeficiency virus.
Centlivre M; Klaver B; Berkhout B; Das AT
J Virol; 2008 Sep; 82(18):9171-8. PubMed ID: 18596090
[TBL] [Abstract][Full Text] [Related]
10. Vaccination of Macaques with DNA Followed by Adenoviral Vectors Encoding Simian Immunodeficiency Virus (SIV) Gag Alone Delays Infection by Repeated Mucosal Challenge with SIV.
Almond N; Berry N; Stebbings R; Preston M; Ham C; Page M; Ferguson D; Rose N; Li B; Mee ET; Hassall M; Stahl-Hennig C; Athanasopoulos T; Papagatsias T; Herath S; Benlahrech A; Dickson G; Meiser A; Patterson S
J Virol; 2019 Nov; 93(21):. PubMed ID: 31413132
[TBL] [Abstract][Full Text] [Related]
11. Construction of doxycyline-dependent mini-HIV-1 variants for the development of a virotherapy against leukemias.
Jeeninga RE; Jan B; van den Berg H; Berkhout B
Retrovirology; 2006 Sep; 3():64. PubMed ID: 17005036
[TBL] [Abstract][Full Text] [Related]
12. Novel, live attenuated simian immunodeficiency virus constructs containing major deletions in leader RNA sequences.
Guan Y; Whitney JB; Liang C; Wainberg MA
J Virol; 2001 Mar; 75(6):2776-85. PubMed ID: 11222701
[TBL] [Abstract][Full Text] [Related]
13. Induction of CD8+ cells able to suppress CCR5-tropic simian immunodeficiency virus SIVmac239 replication by controlled infection of CXCR4-tropic simian-human immunodeficiency virus in vaccinated rhesus macaques.
Tsukamoto T; Yuasa M; Yamamoto H; Kawada M; Takeda A; Igarashi H; Matano T
J Virol; 2007 Nov; 81(21):11640-9. PubMed ID: 17728225
[TBL] [Abstract][Full Text] [Related]
14. CD8 T Cells Show Protection against Highly Pathogenic Simian Immunodeficiency Virus (SIV) after Vaccination with SIV Gene-Expressing BCG Prime and Vaccinia Virus/Sendai Virus Vector Boosts.
Kato S; Shida H; Okamura T; Zhang X; Miura T; Mukai T; Inoue M; Shu T; Naruse TK; Kimura A; Yasutomi Y; Matsuo K
J Virol; 2021 Jan; 95(4):. PubMed ID: 33087465
[TBL] [Abstract][Full Text] [Related]
15. Role of Occult and Post-acute Phase Replication in Protective Immunity Induced with a Novel Live Attenuated SIV Vaccine.
Berry N; Manoussaka M; Ham C; Ferguson D; Tudor H; Mattiuzzo G; Klaver B; Page M; Stebbings R; Das AT; Berkhout B; Almond N; Cranage MP
PLoS Pathog; 2016 Dec; 12(12):e1006083. PubMed ID: 28002473
[TBL] [Abstract][Full Text] [Related]
16. A truncated form of Nef selected during pathogenic reversion of simian immunodeficiency virus SIVmac239Deltanef increases viral replication.
Chakrabarti LA; Metzner KJ; Ivanovic T; Cheng H; Louis-Virelizier J; Connor RI; Cheng-Mayer C
J Virol; 2003 Jan; 77(2):1245-56. PubMed ID: 12502842
[TBL] [Abstract][Full Text] [Related]
17. A doxycycline-dependent human immunodeficiency virus type 1 replicates in vivo without inducing CD4+ T-cell depletion.
Legrand N; van der Velden GJ; Fang RHT; Douaisi M; Weijer K; Das AT; Blom B; Uittenbogaart CH; Berkhout B; Centlivre M
J Gen Virol; 2012 Sep; 93(Pt 9):2017-2027. PubMed ID: 22647372
[TBL] [Abstract][Full Text] [Related]
18. Viral determinants of simian immunodeficiency virus (SIV) virulence in rhesus macaques assessed by using attenuated and pathogenic molecular clones of SIVmac.
Marthas ML; Ramos RA; Lohman BL; Van Rompay KK; Unger RE; Miller CJ; Banapour B; Pedersen NC; Luciw PA
J Virol; 1993 Oct; 67(10):6047-55. PubMed ID: 8371353
[TBL] [Abstract][Full Text] [Related]
19. Forced selection of tRNA(Glu) reveals the importance of two adenosine-rich RNA loops within the U5-PBS for SIV(smmPBj) replication.
Kelly MC; Kosloff BR; Morrow CD
Virology; 2007 Sep; 366(2):330-9. PubMed ID: 17543363
[TBL] [Abstract][Full Text] [Related]
20. Large-scale nucleotide optimization of simian immunodeficiency virus reduces its capacity to stimulate type I interferon in vitro.
Vabret N; Bailly-Bechet M; Lepelley A; Najburg V; Schwartz O; Verrier B; Tangy F
J Virol; 2014 Apr; 88(8):4161-72. PubMed ID: 24478441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
